AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05539482 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-based Health Education based on core intervention package
Description: Community-based Health Education will potentially include the following three components:~1. A manual of emergency preparedness and self-protection against COVID-19 infection. The main content will include hand washing, mask wearing and social distancing guidelines.~2. Early testing. Participants will be trained on how to recognize the early symptoms of COVID-19 and appropriate practice to take in a response, and they will be provided with testing resources.~3. Knowledge of vaccines and their benefits and resources for vaccination.~Collaborators should design and implement health programs based on the core intervention package.
Study NCT06040333 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Dynamic Neuromuscular Stabilisation Exercise
Study NCT06293625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folfox
Description: Folfox chemotherapy (folinic acid, fluorouracil and oxaliplatin) for 6 weeks (3 courses) before surgery.
Study NCT06293625 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: Experimental arm: Surgery should take place 21 days after the last dose of neoadjuvant chemotherapy Control arm: upfront surgery as soon as possible
Study NCT06293625 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Experimental arm: Surgery should take place 21 days after the last dose of neoadjuvant chemotherapy Control arm: upfront surgery as soon as possible
Study NCT05233696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: All patients are encouraged to receive nab-paclitaxel 100 mg/m2 IV D1 and D8 every 21 days (in combination with pembrolizumab) for at least 4-6 cycles per institutional standards and treating physicians' recommendations.
Study NCT05233696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel can be substituted for nab-paclitaxel at the discretion of the treating physician 80 mg/m2 IV D1 and D8 every 21 days.
Study NCT05233696 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: The treating radiation oncologist will select 1-4 sites of metastatic disease to target with radiation. All sites of disease may be targeted with radiation. Sites of metastatic disease planned to be biopsied should not be radiated.
Study NCT05233696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Patients will receive pembrolizumab 200 mg D1 every 21 days.
Study NCT06454019 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phone Outreach
Description: Phone outreach to individuals losing Medicaid and auto-enrolled into Covered California plan to nudge them to act
Study NCT06454019 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Notice
Description: Standard notification letter without phone outreach to individuals losing Medicaid and auto-enrolled into Covered California plan to nudge them to act
Study NCT06473948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX001899
Description: Participants will receive JMKX001899 500mg tablet, orally once on Day 1
Study NCT06530589 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tupler's Technique
Description: Patient will wear diastasis rehab splint and will follow Tupler's techniqe protocol for 6 weeks. In the first 2 weeks both elevator and contracting exercises will be performed and after 2 weeks in the 3rd week only contracting exercises will be perform and for these exercises we divide abdomen into 6 floors and will patient have to contract her tummy towards the 3rd to 5th floor in first week, towards the 4th to 5th floor in 2nd week and from 5th to 6th floor in the 3rd week. in the wek 4 to week 6 head lifts will also be started along with contracting exercises from 5th to 6th floor.
Study NCT06530589 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Exercises
Description: The traditional treatment includes traditional abdominal exercises that patient will be perform for 6 weeks and three times per week with 15 repetitions of each exercise. These exercises includes posterior pelvic tilt' static abdominal contractions', reverse sit up exercise, kegals, russian twist , trunk twist and reverse trunk twist.
Study NCT04659226 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Blood sampling for microRNA testing
Description: Blood samples will be collected and analyzed for the microRNA profile by means of microfluidic cards
Study NCT05362643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Manual acupuncture on acupoint Tai Xi(KI3), bilateral;Sanyinjiao (SP6), bilateral; Zusanli (ST36), bilateral; Shenmen (HT7) unilateral, in the arm without arteriovenous fistula;Guan Yuan (CV4), unilateral, attempt to achieve De qi sensation. After generating needling sensation, needles were manipulated for one minute, every ten minutes during needle retention (20 minutes), using Sterilized stainless steel needle (0,25x25mm; Tewa, asia-med GmbH).
Study NCT05362643 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham Acupuncture
Description: Manual acupuncture performed as superficial needling (5mm depth) on non-acupuncture points without an attempt to achieve De qi sensation and without stimulation, lasting 20 minutes, using Sterilized stainless steel needle (0,25x25mm; Tewa, asia-med GmbH).
Study NCT06473948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX001899
Description: Participants will receive JMKX001899 750mg tablet, orally once on Day 1
Study NCT06473948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX001899
Description: Participants will receive JMKX001899 1000mg tablet, orally once on Day 1
Study NCT06473948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive JMKX001899 matching placebo, tablet, orally once on Day 1
Study NCT05306977 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Open-label accelerated 1 Hz repetitive transcranial magnetic stimulation
Description: Patients will receive a 5-day course of accelerated 1 Hz rTMS (8x session x 600 pulses/session) to the right intraparietal sulcus. Subjects will receive a continuous train of 1 Hz stimulation. They will receive a total of 600 pulses per train. Trains will be separated by \~50 min rest intervals.
Study NCT05485272 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride combined with Potassium Iodide.
Description: Riva Star, Silver diamine fluoride 38% and potassium iodide, SDI, Bayswater, Australia.
Study NCT05485272 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride.
Description: A clear liquid that combines the antibacterial effects of silver and the remineralizing effects of fluoride.
Study NCT05485272 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-Viscosity Glass Ionomer.
Description: A Glass Hybrid material.
Study NCT05905211 — intervention group
Intervention type: OTHER
Intervention: Observational Tests
Description: The Berg Balance Scale was used to evaluate the balance levels, the Timed Up and Go Test was used to evaluate the functional mobility levels, and the Functional Independence Scale was used to evaluate the activities of daily living. The World Health Organization Quality of Life Instrument-Older Adults Module (WHOQOL-OLD) was used to evaluate the quality of life, the Fear of COVID-19 Scale was used to evaluate the COVID-19 fear levels, the Geriatric Depression Scale was used to evaluate the symptoms of depression.
Study NCT04829955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Eccentric manual resistance training
Description: Eccentric bodyweight resistance training
Study NCT04829955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Concentric manual resistance resistance training
Description: Concentric bodyweight resistance training
Study NCT05504148 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: crocin
Description: Take saffron total glucosides tablets for 8 days during each chemotherapy (started on the 1st day before radiotherapy/chemotherapy), 4 tablets/time, 3 times a day.
Study NCT05504148 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Take placebo piece during for 8 days during each chemotherapy (started on the 1st day before radiotherapy/chemotherapy), 4 tablets/time, 3 times a day
Study NCT05516108 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: The mindfulness intervention includes 14 daily 20-minute audio lessons plus brief daily practice prompts. Lessons train specific meditation techniques through didactic explanation and guided practice. Based on the Unified Mindfulness system, lessons train 3 mindfulness skills: concentration, sensory clarity, and equanimity. Concentration, a state of stable attention on the intended target, enables participants to monitor present-moment physical and emotional body experiences. Sensory clarity, the monitoring of momentary experiences, involves detecting subtle sensations and discriminating between different experiences. Equanimity, an attitude of acceptance toward momentary experiences, is trained through 3 strategies: (a) body relaxation, (b) mental welcoming, and (c) a gentle tone of voice. Practice prompts build on the skills trained in each lesson, encouraging participants to practice brief moments of mindful awareness, mindfulness while doing daily tasks, or formal meditation.
Study NCT05516108 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Coping
Description: The coping intervention includes 14 daily 20-minute audio lessons plus brief daily practice prompts. Lessons train specific coping techniques through didactic explanation and guided practice. Lessons train coping skills (reflection, reappraisal, and problem solving) without encouraging focus on or acceptance of present experience (i.e., mindfulness skills). Participants are instructed to: (1) reflect and let their minds drift, (2) reframe or reappraise past and anticipated events, and (3) analyze and solve personal problems. Practice prompts build on the skills trained in each lesson, encouraging participants to take brief reflection breaks or to practice reappraisal or problem-solving skills.
Study NCT06350227 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: the absorbable hemostat and suture
Description: The hemostasis method of the experimental group is to use both the absorbable hemostat and suture.
Study NCT06350227 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: electrocoagulation and suture
Description: The active comparator group is to use electrocoagulation and suture simultaneously to stop bleeding.
Study NCT06350227 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: suture
Description: The placebo comparator is to use suture alone for hemostasis.
Study NCT04708652 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05169307 — intervention group
Intervention type: DRUG
Intervention: CPX-351
Description: This is a retrospective, non-interventional, observational study. No study drug will be administered in this study.
Study NCT05060666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: 2 doses of Ivermectin will be administered with 48 hours time interval.~The dosage is based on body weight calculated as follows:~* 15 mg for 40-60 kg = 5 tablets à 3 mg~* 18 mg for 60-80 kg = 6 tablets à 3 mg~* 24 mg for > 80 kg = 8 tablets à 3 mg each~This corresponds to an ivermectin dose of about 300 µg / kg.
Study NCT05060666 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: An analogous number of tablets is administered for placebo:~* 5 tablets for 40-60 kg~* 6 tablets for 60-80 kg~* 8 tablets for > 80 kg~The size, appearance, smell and taste of the tablets of placebo are identical to Ivermectin.
Study NCT06044831 — intervention group
Intervention type: BEHAVIORAL
Intervention: Expanded Population Health Model
Description: This intervention includes the current population health model in addition to expanded programming from a local community organization. The current population health model with Baylor Scott \& White Health and Wellness Center includes access to primary care, general wellness programs such as cooking classes and nutritional counseling, and evidence-based disease management and prevention. The additional programs from a local community organization focus on human essentials integral to improving health and quality of life and include: health and wellness, economic stability, safe and affordable housing, transportation, a sense of belonging, education, and access to fair credit.
Study NCT05433012 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Ultrahigh Field MRI at 7T
Description: Assessment of the micro-anatomy of the menisci and cartilage in patients with presumed Isolated Acute Anterior Cruciate Ligament Injury with Ultrahigh Field MRI at 7T
Study NCT06132295 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing care
Description: 1. Consistent Schedule for the Replacement of Positioning Line Pens~2. Tailored Educational Content~3. Hypoallergenic Adhesive Patches~4. Enriched Treatment Care Platform~5. Participants with BMI > 25 and an education level of high school or below, without specific caregivers, were identified by placing a red dot on the treatment record and on the patient's happiness card. Patients with BMI \< 25 and an education level of high school or above, with specific caregivers, were identified by placing a green dot on their records.~6. Individual interventions, educational pamphlets prepared in-house were added, to assess the maintenance status of the positioning marks.
Study NCT06213246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Hygiene Strategies
Description: The sleep hygiene strategies will be applied for all seven days of Week 3 and will involve the following guidelines recommended by the National Sleep Foundation~* Maintain a consistent wake-up and bedtime schedule during workdays.~* Do not delay/advance excessively (no more than 2 hours) the wake-up and bedtime - schedule during weekends.~* Keep the bedroom temperature below 22°C.~* Avoid sources of light and noise in the bedroom.~* Use the bed only for sleeping, avoiding other activities before bedtime.~* Avoid daytime naps during workdays.~* Refrain from using electronic devices (PC, laptop, cellphone, television) at least 30 minutes before bedtime.~* Expose yourself to natural light in the morning and reduce artificial lights in the evening.~* Avoid consuming alcoholic beverages and caffeine in the afternoon.~* Have a moderately sized dinner at least 3 hours before bedtime.
Study NCT05779969 — intervention group
Intervention type: OTHER
Intervention: Chest CT scan
Description: Comparison of structural damage to the manubriosternal joint (MST) between a population of patients with radiographic axSpA and a control population free of chronic inflammatory rheumatism on chest CT.
Study NCT05430152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-Dose Naltrexone
Description: Study drug dosing schedule (LDN):~* Week 1: 1 mg/day (1 mg cap)~* Week 2: 2 mg/day (two 1 mg caps)~* Week 3: 3 mg/day (three 1mg caps)~* Weeks 4-6: 4.5 mg/day (three 1 mg caps, plus one 1.5 mg cap = 4.5 mg/day)~* Weeks 7-16: 4.5 mg/day (one 4.5 mg cap) OR based on self-titration dosage (one 1mg, 2mg, or 3mg cap)
Study NCT05430152 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study drug dosing schedule (Placebo; capsules made to match LDN doses):~* Week 1: 1 mg/day (1 mg cap)~* Week 2: 2 mg/day (two 1 mg caps)~* Week 3: 3 mg/day (three 1mg caps)~* Weeks 4-6: 4.5 mg/day (three 1 mg caps, plus one 1.5 mg cap = 4.5 mg/day)~* Weeks 7-16: 4.5 mg/day (one 4.5 mg cap) OR based on self-titration dosage (one 1mg, 2mg, or 3mg cap)
Study NCT06556589 — intervention group
Intervention type: BEHAVIORAL
Intervention: Collaborative Care
Description: Collaborative care components include patient-centered team care, population-based care, measurement-based treatment to target, evidence-based care, and accountable care.
Study NCT04923256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AAT-APP: A novel smart-phone approach-avoidance bias modification intervention
Description: Participants allocated to the intervention group will be required to upload photos of drinks they wish to avoid, as well as activities they wish to engage in more, and be trained to avoid and approach by repeatedly 'swiping' images away from and towards themselves, respectively.
Study NCT04923256 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sham training control
Description: Complete an AAT on a weekly basis for four weeks
Study NCT06071208 — intervention group
Intervention type: DRUG
Intervention: Gliflozin
Description: to study whether the use of gliflozin prevented diabetic complications
Study NCT06504498 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 0.5 mm-thick Duran® clear aligner
Description: 0.5 mm-thick clear aligner was used for orthodontic treatment.
Study NCT06504498 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 0.75 mm-thick Duran® clear aligner
Description: 0.75 mm-thick clear aligner was used for orthodontic treatment.
Study NCT06040333 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard therapy
Description: Patient education, massage, diaphragmatic breathing, kegel exercise
Study NCT05966311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous Ultrasound Gastrostomy
Description: Ultrasound guided placement of gastrostomy tube using the PUMA-G Pediatric System
Study NCT06040333 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard therapy
Description: Patient education, massage, diaphragmatic breathing, kegel exercise
Study NCT06521892 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: social surveillance and health education interventions
Description: Social surveillance: In the intervention group retail pharmacies posted or hung signs antibiotics need to be purchased by prescription, if found without prescription sales, welcome to call 12315 hotline to report, to form social supervision intervention.~Health education: On-site training for retail pharmacy staff, inviting respiratory physicians and pediatricians to give health education lectures on disease diagnosis, treatment and medication.
Study NCT06443255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cociane hydrochloride 4%
Description: 2 mL of 4% cocaine
Study NCT06443255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine 4%
Description: 1.5 mL of 4% lidocaine
Study NCT06443255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xylometazoline 0.1%
Description: 0.5 mL of xylometazoline 0.1%
Study NCT06443255 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline 0.9%
Description: 2 mL of saline 0.9%
Study NCT05505968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset
Description: Virtual Reality Headset of the society Healthy Mind and is a CE Class 1 medical device. This virtual reality headset is a Pico G2 4K and corresponds to the model A7510 and is connected to a Bose Sound Link 2 AE headset.
Study NCT05236842 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sulthiame
Description: oral
Study NCT05236842 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulthiame
Description: oral
Study NCT06630910 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreaticojejunostomy without stenting and omental patch
Description: A traditional pancreaticoduodenectomy with pylorus preservation was performed on each patient. A pancreaticojejunostomy was created by double-layered, end-to-side, duct-to-mucosa anastomosis between the primary pancreatic duct and jejunal wall without stenting or omental patch.
Study NCT06630910 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreaticojejunostomy with stenting and omental patch
Description: A traditional pancreaticoduodenectomy with pylorus preservation was performed on each patient. A pancreaticojejunostomy was created by double-layered, end-to-side, duct-to-mucosa anastomosis between the primary pancreatic duct and jejunal wall, a nelaton stent 6f was inserted into the pancreatic duct and jejunum of each patient receiving PJ. The larger omentum was separated longitudinally over an avascular zone, and one or two omental branches of the gastroepiploic arteries were preserved using pedicle omental flaps. The omental flap was pushed between the posterior surface of PJ and the portal vein, then wrapped over the anterior surface of PJ. The omentum was rolled up and secured with a few PDS sutures.
Study NCT05907720 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Human-centered design prototype solutions for vulnerable pregnant women
Description: The intervention package will include various social and behavior change programs derived from a human-centered design approach. The intervention will be tailored to vulnerable pregnant women's needs and contexts. It may include but is not limited to health communication campaigns, including radio and print media.
Study NCT06054269 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FLUAD Quadrivalent
Description: 0.5 mL intramuscular dose of FLUAD Quadrivalent
Study NCT06054269 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FluQuadri
Description: 0.5 mL intramuscular dose of FluQuadri